HomeInsightsStock Comparison

Gpt Healthcare Ltd vs Transgene Biotek Ltd Stock Comparison

Gpt Healthcare Ltd vs Transgene Biotek Ltd Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

  • The Latest Trading Price of GPT Healthcare Ltd is ₹ 131.95 as of 23 Oct 15:30 . The P/E Ratio of GPT Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of GPT Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Transgene Biotek Ltd changed from ₹ 34.7 crore on March 2021 to ₹ 25.38 crore on March 2025 . This represents a CAGR of -6.06% over 5 years The revenue of GPT Healthcare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Transgene Biotek Ltd for the Jun '26 is ₹ 0.06 crore as compare to the Mar '26 revenue of ₹ 0.2 crore. This represent the decline of -70% The ebitda of GPT Healthcare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Transgene Biotek Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.13 crore. This represent the decline of -53.85% The net profit of GPT Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Transgene Biotek Ltd changed from ₹ 0.2 crore to ₹ -0.39 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of GPT Healthcare Ltd changed from 46.79 % on March 2021 to 48.58 % on March 2026 . This represents a CAGR of 0.63% over 6 yearsThe Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About GPT Healthcare Ltd

  • GPT Healthcare Limited was formerly established as 'Jibansatya Printing House Private Limited' on August 17, 1989 at Kolkata, West Bengal.
  • The name of Company was changed to 'GPT Healthcare Private Limited' by the Registrar of Companies on March 31, 2005.
  • Thereafter, Company converted to a Public Company and the name was changed to 'GPT Healthcare Limited'.
  • Consequent upon change in name to a Limited Company, a fresh Certificate of Incorporation was issued by the RoC on September 15, 2021. The principal activities of the Company include operation of multidisciplinary private hospitals and pharmacies.
  • The Company is having four Multispecialty hospitals.

About Transgene Biotek Ltd

  • Founded in March 1990 by Dr. Koteswara Rao, Transgene Biotek Limited was one of the first Biotechnology companies in India.
  • Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
  • The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

FAQs for the comparison of GPT Healthcare Ltd and Transgene Biotek Ltd

Which company has a larger market capitalization, GPT Healthcare Ltd or Transgene Biotek Ltd?

Market cap of GPT Healthcare Ltd is 1,082 Cr while Market cap of Transgene Biotek Ltd is 19 Cr

What are the key factors driving the stock performance of GPT Healthcare Ltd and Transgene Biotek Ltd?

The stock performance of GPT Healthcare Ltd and Transgene Biotek Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for GPT Healthcare Ltd and Transgene Biotek Ltd?

As of October 25, 2026, the GPT Healthcare Ltd stock price is INR ₹131.95. On the other hand, Transgene Biotek Ltd stock price is INR ₹2.57.

How do dividend payouts of GPT Healthcare Ltd and Transgene Biotek Ltd compare?

To compare the dividend payouts of GPT Healthcare Ltd and Transgene Biotek Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions